Discover the full record of transactions filed by 이정민, Chief Executive Officer. Officer active across 2 companies, notably 아이엠바이오로직스. In total, 17,943 reports have been recorded. Activity tracked since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Lee Jeong-min is the executive director at IM Biologics, where he oversees the company's operations and strategies. With a strong background in the biotechnology sector, he is responsible for implementing initiatives aimed at fostering innovation and growth. His leadership is essential in guiding IM Biologics towards a prosperous future.